A citation-based method for searching scientific literature

Roshan Cools, Lee Altamirano, Mark D'Esposito. Neuropsychologia 2006
Times Cited: 214







List of co-cited articles
979 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


By carrot or by stick: cognitive reinforcement learning in parkinsonism.
Michael J Frank, Lauren C Seeberger, Randall C O'reilly. Science 2004
47


Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients.
Nikoletta Bódi, Szabolcs Kéri, Helga Nagy, Ahmed Moustafa, Catherine E Myers, Nathaniel Daw, György Dibó, Annamária Takáts, Dániel Bereczki, Mark A Gluck. Brain 2009
233
27



Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans.
Mathias Pessiglione, Ben Seymour, Guillaume Flandin, Raymond J Dolan, Chris D Frith. Nature 2006
881
21

Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration.
Roshan Cools, Michael J Frank, Sasha E Gibbs, Asako Miyakawa, William Jagust, Mark D'Esposito. J Neurosci 2009
257
20

A neural substrate of prediction and reward.
W Schultz, P Dayan, P R Montague. Science 1997
20



Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning.
Marieke E van der Schaaf, Martine R van Schouwenburg, Dirk E M Geurts, Arnt F A Schellekens, Jan K Buitelaar, Robbert Jan Verkes, Roshan Cools. Cereb Cortex 2014
64
28


Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Daniel Weintraub, Juergen Koester, Marc N Potenza, Andrew D Siderowf, Mark Stacy, Valerie Voon, Jacqueline Whetteckey, Glen R Wunderlich, Anthony E Lang. Arch Neurol 2010
861
17

L-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease.
Roshan Cools, Simon J G Lewis, Luke Clark, Roger A Barker, Trevor W Robbins. Neuropsychopharmacology 2007
197
16

Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism.
Michael J Frank, Johan Samanta, Ahmed A Moustafa, Scott J Sherman. Science 2007
697
16

Pharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.
Stefano Palminteri, Maël Lebreton, Yulia Worbe, David Grabli, Andreas Hartmann, Mathias Pessiglione. Proc Natl Acad Sci U S A 2009
91
16


Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task.
Robb B Rutledge, Stephanie C Lazzaro, Brian Lau, Catherine E Myers, Mark A Gluck, Paul W Glimcher. J Neurosci 2009
148
15

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease.
Roshan Cools, Roger A Barker, Barbara J Sahakian, Trevor W Robbins. Neuropsychologia 2003
357
15

Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors.
Valerie Voon, Mathias Pessiglione, Christina Brezing, Cecile Gallea, Hubert H Fernandez, Raymond J Dolan, Mark Hallett. Neuron 2010
202
14



Medication impairs probabilistic classification learning in Parkinson's disease.
Marjan Jahanshahi, Leonora Wilkinson, Harpreet Gahir, Angeline Dharmaindra, David A Lagnado. Neuropsychologia 2010
82
14


Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning.
Michael J Frank, Ahmed A Moustafa, Heather M Haughey, Tim Curran, Kent E Hutchison. Proc Natl Acad Sci U S A 2007
408
11


On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
Diana Maria Elena Torta, Lorys Castelli, Maurizio Zibetti, Leonardo Lopiano, Giuliano Geminiani. Brain Cogn 2009
36
30

Dopamine and performance in a reinforcement learning task: evidence from Parkinson's disease.
Tamara Shiner, Ben Seymour, Klaus Wunderlich, Ciaran Hill, Kailash P Bhatia, Peter Dayan, Raymond J Dolan. Brain 2012
105
11

Parkinsonism: onset, progression and mortality.
M M Hoehn, M D Yahr. Neurology 1967
10

Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes.
Sylvia M L Cox, Michael J Frank, Kevin Larcher, Lesley K Fellows, Crystal A Clark, Marco Leyton, Alain Dagher. Neuroimage 2015
99
10



Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition.
J B Rowe, L Hughes, B C P Ghosh, D Eckstein, C H Williams-Gray, S Fallon, R A Barker, A M Owen. Brain 2008
137
9



Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.
T D L Steeves, J Miyasaki, M Zurowski, A E Lang, G Pellecchia, T Van Eimeren, P Rusjan, S Houle, A P Strafella. Brain 2009
344
9

Probabilistic reversal learning is impaired in Parkinson's disease.
D A Peterson, C Elliott, D D Song, S Makeig, T J Sejnowski, H Poizner. Neuroscience 2009
50
18

L-dopa impairs learning, but spares generalization, in Parkinson's disease.
Daphna Shohamy, Catherine E Myers, Kindiya D Geghman, Jacob Sage, Mark A Gluck. Neuropsychologia 2006
116
8


Differential influence of levodopa on reward-based learning in Parkinson's disease.
Susanne Graef, Guido Biele, Lea K Krugel, Frank Marzinzik, Michael Wahl, Johann Wotka, Fabian Klostermann, Hauke R Heekeren. Front Hum Neurosci 2010
35
22


A role for dopamine in temporal decision making and reward maximization in parkinsonism.
Ahmed A Moustafa, Michael X Cohen, Scott J Sherman, Michael J Frank. J Neurosci 2008
87
8

Working memory capacity predicts dopamine synthesis capacity in the human striatum.
Roshan Cools, Sasha E Gibbs, Asako Miyakawa, William Jagust, Mark D'Esposito. J Neurosci 2008
189
7

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.
C H Williams-Gray, T Foltynie, C E G Brayne, T W Robbins, R A Barker. Brain 2007
604
7

Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?
Thilo van Eimeren, Bénédicte Ballanger, Giovanna Pellecchia, Janis M Miyasaki, Anthony E Lang, Antonio P Strafella. Neuropsychopharmacology 2009
114
7

Motivation, reward, and Parkinson's disease: influence of dopatherapy.
V Czernecki, B Pillon, J L Houeto, J B Pochon, R Levy, B Dubois. Neuropsychologia 2002
256
7

Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome.
Andrew H Evans, Regina Katzenschlager, Dominic Paviour, John D O'Sullivan, Silke Appel, Andrew D Lawrence, Andrew J Lees. Mov Disord 2004
349
7


L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction.
K W Lange, T W Robbins, C D Marsden, M James, A M Owen, G M Paul. Psychopharmacology (Berl) 1992
427
7

Impulse control disorders in Parkinson disease: a multicenter case--control study.
Valerie Voon, Mandy Sohr, Anthony E Lang, Marc N Potenza, Andrew D Siderowf, Jacqueline Whetteckey, Daniel Weintraub, Glen R Wunderlich, Mark Stacy. Ann Neurol 2011
254
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.